Related Experiment Videos
Induced circular dichroism in nucleic acid-acridine derivative complexes
Nucleic Acids Symposium Series
|January 1, 1989
Summary
This study investigated how 9-aminoacridines bind to different nucleic acids. The cationic side chains of these drugs significantly influence their binding properties to DNA and RNA, affecting spectral characteristics.
Area of Science:
- Biophysical Chemistry
- Molecular Biology
- Pharmacology
Background:
- 9-aminoacridines are a class of compounds with potential therapeutic applications.
- Understanding their interaction with nucleic acids is crucial for drug development.
- Nucleic acid structure and dynamics can be modulated by small molecule binding.
Purpose of the Study:
- To investigate the binding interactions between 9-aminoacridines and various nucleic acids.
- To characterize the spectral changes upon complex formation.
- To elucidate the role of drug structure, specifically cationic side chains, in binding affinity and mode.
Main Methods:
- Visible absorption spectroscopy to detect spectral shifts and new absorption bands.
- Circular Dichroism (CD) spectroscopy to analyze conformational changes and binding modes.
- Complexation studies involving calf thymus DNA, poly(rA).poly(rU), and poly(rI).poly(rC) with quinacrine, acranil, and 9-amino-6-chloro-2-methoxy acridine.
Main Results:
- Complexes formed between nucleic acids and 9-aminoacridines exhibited distinct visible absorption and induced Circular Dichroism (CD) spectra.
- A novel absorption band at longer wavelengths was observed for poly(rA).poly(rU) complexes.
- Induced CD spectra varied significantly among different nucleic acid-drug combinations, indicating diverse binding interactions.
Conclusions:
- The cationic side chains of quinacrine and acranil are critical determinants of their binding properties to DNA and poly(rA).poly(rU).
- Spectral analysis provides insights into the molecular mechanisms of drug-nucleic acid interactions.
- These findings contribute to the rational design of novel nucleic acid-targeting agents.